Thurston, Springer, Miller, Herd & Titak, Inc. Novartis Ag Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $46.2 Million
- Q3 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 6 shares of NVS stock, worth $781. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6
Previous 1,816
99.67%
Holding current value
$781
Previous $219,000
100.0%
% of portfolio
0.0%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,560Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.35 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.18 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$985 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$928 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $280B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...